Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v5-EN
Language English English
Date Updated 2023-12-22 2023-12-21
Drug Identification Number 02302853 02302853
Brand name EXELON PATCH 10 EXELON PATCH 10
Common or Proper name Rivastigmine Transdermal Patch Rivastigmine Transdermal Patch
Company Name KNIGHT THERAPEUTICS INC. KNIGHT THERAPEUTICS INC.
Ingredients RIVASTIGMINE RIVASTIGMINE
Strength(s) 9.5MG 9.5MG
Dosage form(s) PATCH PATCH
Route of administration TRANSDERMAL TRANSDERMAL TRANSDERMAL TRANSDERMAL
Packaging size 9.5 mg/24hr 9.5 mg/24hr
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-11-17 2023-11-17
Estimated end date 2023-12-31
Actual end date 2023-12-21 2023-12-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product in stock as of Dec 21, 2023
Health Canada comments